TrialInvestigational new drugs2013

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study.

M Martin-Richard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.